Literature DB >> 12667800

Identification of RNA ligands that bind hepatitis C virus polymerase selectively and inhibit its RNA synthesis from the natural viral RNA templates.

Nam Viet Vo1, Jong-Won Oh, Michael M C Lai.   

Abstract

To identify the potential RNA inhibitors of HCV polymerase, we have isolated high-affinity RNA ligands specific to hepatitis C virus (HCV) NS5B protein from a combinatorial RNA library using the Systematic Evolution of Ligands by EXponential enrichment (SELEX) procedure. Thirty-seven selected ligands were classified into eight groups on the basis of their sequence homologies. Most (60%) of the ligands carry the conserved YGUAGR hexamer (Y = pyrimidine, R = purine) at the 5' end of the 40-nt randomized region, and 74% of the ligands end in (A/C)U at the 3'end. However, strong binding to NS5B required the whole RNA ligand including the flanking conserved nucleotides at both ends. The binding of the selected ligands to NS5B is highly specific and strong, as reflected in their low dissociation rate constants (k(d) approximately 10(-4) s(-1)). Analysis of secondary structure by computer program and RNase footprints of the two different aptamers from two most conserved groups revealed RNA structures containing three stem loops with internal bulges. NS5B bound these RNA at a region between the two stem loops from the 5' -end. Some of these RNA aptamers could serve as a template for the HCV polymerase, but some interfered with the activity of the viral enzyme. These RNA ligands will be useful for further characterization of NS5B-binding properties and, with further modifications, may have potential therapeutic value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667800     DOI: 10.1016/s0042-6822(02)00095-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.

Authors:  Louisa A Jones; Leighton E Clancy; William D Rawlinson; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  RNA sequence and secondary structure participate in high-affinity CsrA-RNA interaction.

Authors:  Ashok K Dubey; Carol S Baker; Tony Romeo; Paul Babitzke
Journal:  RNA       Date:  2005-08-30       Impact factor: 4.942

3.  A mathematical analysis of SELEX.

Authors:  Howard A Levine; Marit Nilsen-Hamilton
Journal:  Comput Biol Chem       Date:  2007-01-10       Impact factor: 2.877

4.  Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus.

Authors:  Mark Ellingham; David H J Bunka; David J Rowlands; Nicola J Stonehouse
Journal:  RNA       Date:  2006-10-03       Impact factor: 4.942

5.  Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A.

Authors:  Masaru Moriyama; Naoya Kato; Motoyuki Otsuka; Run-Xuan Shao; Hiroyoshi Taniguchi; Takao Kawabe; Masao Omata
Journal:  Hepatol Int       Date:  2007-06       Impact factor: 6.047

6.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

7.  Primary and Secondary Sequence Structure Requirements for Recognition and Discrimination of Target RNAs by Pseudomonas aeruginosa RsmA and RsmF.

Authors:  Kayley H Schulmeyer; Manisha R Diaz; Thomas B Bair; Wes Sanders; Cindy J Gode; Alain Laederach; Matthew C Wolfgang; Timothy L Yahr
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

8.  Recombinant viral RdRps can initiate RNA synthesis from circular templates.

Authors:  C T Ranjith-Kumar; C C Kao
Journal:  RNA       Date:  2005-12-22       Impact factor: 4.942

9.  Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Authors:  Pantxika Bellecave; Christian Cazenave; Julie Rumi; Cathy Staedel; Ophélie Cosnefroy; Marie-Line Andreola; Michel Ventura; Laura Tarrago-Litvak; Thérèse Astier-Gin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

10.  NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase.

Authors:  Serena Vegna; Damien Gregoire; Marie Moreau; Patrice Lassus; David Durantel; Eric Assenat; Urszula Hibner; Yannick Simonin
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.